{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:38:06Z","timestamp":1772001486089,"version":"3.50.1"},"reference-count":20,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s470632","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T10:47:10Z","timestamp":1731494830000},"page":"827-837","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics of High-Cost Beneficiaries of Prescription Drugs in Kazakhstan: A Cross-Sectional Study of Outpatient Data from 2022"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Adilet","family":"Nazarbayev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardak","family":"Nurbakyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-4943","authenticated-orcid":true,"given":"Bibigul","family":"Omirbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuar","family":"Akhmetzhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-4345","authenticated-orcid":true,"given":"Lyazzat","family":"Kosherbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e0304023","DOI":"10.1371\/journal.pone.0304023","volume":"19","author":"Endalamaw","year":"2024","journal-title":"PLoS One"},{"key":"ref2","unstructured":"The selection and use of essential medicines: report of the WHO expert committee on selection and use of essential medicines, 2023 (including the 23rd WHO model list of essential medicines and the 9th WHO model list of essential medicines for children). Geneva: World Health Organization; 2024."},{"key":"ref3","unstructured":"Ministry of Health in Kazakhstan. The 117 names of medicines were not authorized on the market of the Republic of Kazakhstan, news of the ministry of health. (Russian). February 10, 2023. (Russian) https:\/\/www.gov.kz\/memleket\/entities\/dsm\/press\/news\/details\/503921?lang=ru. Accessed February 10, 2024."},{"key":"ref4","unstructured":"The Ministry of Health Single Distributer. (Russian). Available from: https:\/\/sk-pharmacy.kz\/. Accessed November 7, 2024."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10198-012-0393-8","volume":"14","author":"Saastamoinen","year":"2013","journal-title":"Eur J Health Econ"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e2125179","DOI":"10.1001\/jamanetworkopen.2021.25179","volume":"4","author":"Holle","year":"2021","journal-title":"JAMA Network Open"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.9778\/cmajo.20190231","volume":"8","author":"Tadrous","year":"2020","journal-title":"CMAJ Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.18553\/jmcp.2016.22.2.102","volume":"22","author":"Pritchard","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"ref9","doi-asserted-by":"publisher","volume-title":"The Economics of Public Health Care Reform in Advanced and Emerging Economies","year":"2012","DOI":"10.5089\/9781616352448.071.ch010"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e023113","DOI":"10.1136\/bmjopen-2018-023113","volume":"8","author":"Wammes","year":"2018","journal-title":"BMJ Open"},{"key":"ref11","unstructured":"Compulsory health insurance fund of the Republic of Kazakhstan on the progress of the implementation of compulsory social health insurance. Available from: https:\/\/egov.kz\/cms\/en\/articles\/health_care\/osms. Accessed November 7, 2024."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"11412","DOI":"10.3390\/ijerph191811412","volume":"19","author":"Oortwijn","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/pds.3764","volume":"24","author":"Saastamoinen","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1007\/s11606-021-07165-x","volume":"37","author":"Park","year":"2022","journal-title":"J Gen Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1472-6904-9-11","volume":"9","author":"Hovstadius","year":"2009","journal-title":"BMC Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/1475-6773.12492","volume":"52","author":"Weymann","year":"2017","journal-title":"Health Serv Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13561-024-00519-1","volume":"14","author":"Ng","year":"2024","journal-title":"Health Econ Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12325-022-02359-z","volume":"40","author":"Dabbous","year":"2023","journal-title":"Adv Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00228-010-0940-0","volume":"67","author":"Pappa","year":"2011","journal-title":"Eur J Clin Pharmacol"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/97242","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/97242","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T10:47:14Z","timestamp":1731494834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/characteristics-of-high-cost-beneficiaries-of-prescription-drugs-in-ka-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2147\/ceor.s470632","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}